Greetings,
The AHNS Basic and Translational Science Committee of the Research Division, is pleased to present a free webinar on:
Immunotherapy for Mucosal HNC – Discussion of the Current Landscape and Visions for the Future.
Date: Wednesday, March 27, 2024
Time: 7:00pm EST /4:00pm PST
Hosts: Natalie Silver & Carissa M. Thomas
Moderator: Chad Brenner
Panelists: Ravindra Uppaluri; Clint T. Allen; Sana Karam; and Tullia C. Bruno
Objectives:
- Identify the current state and application of immune checkpoint inhibitors in the head and neck squamous cell carcinoma clinical practice.
- Describe emerging concepts in understanding the efficacy of immune checkpoint inhibitors and implementation in the neoadjuvant, adjuvant, and metastatic/recurrent setting.
- Articulate the limitations of immunotherapy in head and neck cancer treatment and discuss the future potential.
The webinar will cover key topics such as:
- Neoadjuvant anti-PD1 therapy impact on T cell dynamics and clinical implications- Dr. Ravindra Uppaluri
- Abrogation of TGF-b-associated tissue residency of tumor-specific T cells to enhance systemic immunity in head and neck cancer– Dr. Clint Allen
- Integration of Radiation and Immunotherapy– Dr. Sana Karam
- Leveraging B cells inside and outside of tertiary lymphoid structures for improved immunity in head and neck cancer– Dr. Tullia Bruno
